Anixa Directors Say Option Price, Patent News Not Related
Anixa Biosciences Inc. directors told a Delaware Chancery Court judge Friday that an investor was incorrect to tie a repricing of employee stock options to a beneficial ruling on a company...To view the full article, register now.
Already a subscriber? Click here to view full article